Cargando…
Fundamental and Essential Knowledge for Pathologists Engaged in the Research and Practice of Immune Checkpoint Inhibitor-Based Cancer Immunotherapy
Extensive research over 100 years has demonstrated that tumors can be eliminated by the autologous immune system. Without doubt, immunotherapy is now a standard treatment along with surgery, chemotherapy, and radiotherapy; however, the field of cancer immunotherapy is continuing to develop. The curr...
Autores principales: | Kubo, Terufumi, Shinkawa, Tomoyo, Kikuchi, Yasuhiro, Murata, Kenji, Kanaseki, Takayuki, Tsukahara, Tomohide, Hirohashi, Yoshihiko, Torigoe, Toshihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289279/ https://www.ncbi.nlm.nih.gov/pubmed/34290982 http://dx.doi.org/10.3389/fonc.2021.679095 |
Ejemplares similares
-
IL‐13 modulates ∆Np63 levels causing altered expression of barrier‐ and inflammation‐related molecules in human keratinocytes: A possible explanation for chronicity of atopic dermatitis
por: Kubo, Terufumi, et al.
Publicado: (2021) -
Identification of characteristic subepithelial surface granulomatosis in immune‐related adverse event‐associated enterocolitis
por: Kubo, Terufumi, et al.
Publicado: (2021) -
Occult ovarian clear-cell carcinoma diagnosed as primary adenocarcinoma of the lung: A case report of a diagnostic pitfall for clinicians and pathologists
por: Kubo, Terufumi, et al.
Publicado: (2018) -
Implication of chemo‐resistant memory T cells for immune surveillance in patients with sarcoma receiving chemotherapy
por: Shibayama, Yuji, et al.
Publicado: (2017) -
Immune responses to human cancer stem‐like cells/cancer‐initiating cells
por: Hirohashi, Yoshihiko, et al.
Publicado: (2015)